Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD
Table 3
Comparison of evaluation moments and groups in relation to body composition, lung function, 6MWT, and BODE index.
N = 26
Control group (N = 13)
Intervention group (N = 13)
time
group
TxG
Hospitalization
After one month
Hospitalization
After one month
BMI
23.3 ± 4.4
24.2 ± 6.1
25.4 ± 4.8
26.5 ± 5.09
0.89
0.18
0.33
LBMI
16.0 ± 3.6
15.6 ± 6.8
15.7 ± 2.1
17.5 ± 2.1
0.36
0.45
0.38
FEV1 (%)
39.0 ± 9.6
40.4 ± 15.0
32.6 ± 15.2
40.9 ± 14.1
0.05
0.51
0.45
FEV1 (L)
0.89 ± 0.29
1.02 ± 0.41
0.74 ± 0.32
0.91 ± 0.28
0.12
0.75
0.4
FVC (%)
60.1 ± 12.2
68.7 ± 18.2
55.7 ± 18.8
63.5 ± 18.5
0.09
0.89
0.55
FVC (L)
1.82 ± 0.64
2.05 ± 0.78
1.63 ± 0.57
1.82 ± 0.51
0.23
0.87
0.49
FEV1/FVC (L)
0.45 ± 0.09
0.50 ± 0.09
0.45 ± 0.09
0.50 ± 0.10
0.05
0.95
0.95
BODE
5.6 ± 1.9
5.0 ± 2.3
6.3 ± 1.7
4.4 ± 2.0
0.002
0.85
0.24
6MWT
219.0 ± 38.4
269.5 ± 28.1
190.7 ± 40.3
277.4 ± 29.5
0.02
0.97
0.26
Values are expressed as mean ± standard deviation. LBMI, lean body mass index; BMI, body mass index; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; 6MWT, six-minute walk test; BODE, body mass index, airway obstruction, dyspnea, and exercise capacity; , comparison evaluated by the two-way ANOVA test with repeated measures.
